Boston Scientific Corporation (NYSE:BSX) announced the launch and first U.S. implant of its line of Extended Longevity (EL) implantable cardioverter defibrillators (ICD), including DYNAGEN(TM) EL and INOGEN(TM) EL device models. The first EL ICD was implanted at The University of Pittsburgh Medical Center (UPMC) by Dr. Samir Saba. On Monday shares of Boston Scientific Corporation (NYSE:BSX) closed at $14.61. Company’s sales growth for last 5 years was -2.40% and EPS growth for next 5 years is recorded as 10.56%.
On 26 January Crestwood Equity Partners LP (NYSE:CEQP) named Robert Halpin finance chief of Crestwood Equity GP LLC, its general partner, effective March 31, according to a regulatory filing. Mr. Halpin is vice president of finance at Crestwood Equity GP. Crestwood Equity Partners LP (NYSE:CEQP) in last trading activity advanced 7.74% to close at $7.52. Company weekly performance is 5.32% while its quarterly performance stands at -15.60%. Crestwood Equity Partners LP (NYSE:CEQP) is -49.84% away from its 52 week high.
On 29 January Westpac Banking Corporation (NYSE:WBK) has inked a deal to sell its operations in five Pacific Island nations for $125 million. The bank will offload its banking operations in Samoa, Cook Islands, Solomon Islands, Vanuatu and Tonga to the Bank of South Pacific Limited (BSP). On last trading day Westpac Banking Corporation (NYSE:WBK) advanced 2.28% to close at $27.36. Its volatility for the week is 1.29% while volatility for the month is 1.27%. WBK’s sales growth for past 5 years was 1.20% and its EPS growth for past 5 years was 14.20%. Westpac Banking Corporation (NYSE:WBK) monthly performance is 1.71%.
Based on its recent analysis of the solar inverter market, Frost & Sullivan on 28 January recognizes Enphase Energy, Inc. (NASDAQ:ENPH) with the 2014 Global Frost & Sullivan Award for Technology Leadership. Enphase Energy, Inc. (NASDAQ:ENPH) has 12.90% insider ownership while its institutional ownership stands at 80.40%. In last trading activity company’s stock closed at $13.17.
Maxim Group upgraded shares of NIC (NASDAQ:EGOV) from a sell rating to a hold rating in a research report sent to investors on Friday morning, TheFlyOnTheWall.com reports. The firm currently has $17.00 price target on the stock, up from their previous price target of $15.00. On last trading day NIC Inc. (NASDAQ:EGOV) advanced 1.83% to close at $16.72. Its volatility for the week is 3.62% while volatility for the month is 3.29%. EGOV’s sales growth for past 5 years was 19.90% and its EPS growth for past 5 years was 20.40%. NIC Inc. (NASDAQ:EGOV) monthly performance is -7.06%.